Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Aug 28;15(8):e44269.
doi: 10.7759/cureus.44269. eCollection 2023 Aug.

The Promising Therapeutic Potential of Celastrol for Fibrotic Diseases: A Systematic Literature Review on Its Mechanism

Nurin Yasmin Mohd Khairudin  1 , Nasibah Azme  1 , Nurdiyana Nasrudin  1 , Siti Aznida Ab Karim  1
Affiliations
Review

The Promising Therapeutic Potential of Celastrol for Fibrotic Diseases: A Systematic Literature Review on Its Mechanism

Nurin Yasmin Mohd Khairudin et al. Cureus. .

Abstract

Celastrol is a pentacyclic tripterine sourced from Tripterygium wilfordii hook root. Celastrol can exert certain biological functions such as antitumor, anti-inflammatory, and antiproliferative properties. Celastrol was shown from the previous literature to be capable of attenuating many fibrotic diseases. As the effects of various fibrotic diseases such as atherosclerosis, cancer, and ischemia affect more people with devastating repercussions, this warrants celastrol to be exploited as a phytotherapeutic drug. The purpose of this study is to review previous research and identify the proposed therapeutic mechanisms of celastrol in fibrotic diseases focusing on both the in vitro and in vivo experimental models. A systematic literature search on Web of Science (WoS), Scopus, and ScienceDirect that included articles published between 2012 and 2022 was carried out using the keywords "celastrol", "tripterine", "fibrotic disease", and "fibrosis". After screening the initial search yield of 405 articles, 25 articles were included in this review. The study findings summarize the potential therapeutic mechanism of celastrol in the attenuation of fibrotic diseases in in vivo and in vitro experimental models. It shows that celastrol is useful as a treatment means. However, more studies are needed on the effects of celastrol on humans to carry out clinical trials to verify the long-term benefits of celastrol.

Keywords: celastrol; fibrotic diseases; in vitro; in vivo; mechanism of action.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Study Flowchart
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Wynn TA, Ramalingam TR. Nat Med. 2012;18:1028–1040. - PMC - PubMed
    1. Cellular and molecular mechanisms of fibrosis. Wynn TA. J Pathol. 2008;214:199–210. - PMC - PubMed
    1. Evasion of apoptosis by myofibroblasts: a hallmark of fibrotic diseases. Hinz B, Lagares D. Nat Rev Rheumatol. 2020;16:11–31. - PMC - PubMed
    1. Shared and distinct mechanisms of fibrosis. Distler JH, Györfi AH, Ramanujam M, Whitfield ML, Königshoff M, Lafyatis R. Nat Rev Rheumatol. 2019;15:705–730. - PubMed
    1. Targeting metabolic dysregulation for fibrosis therapy. Zhao X, Kwan JY, Yip K, Liu PP, Liu FF. Nat Rev Drug Discov. 2020;19:57–75. - PubMed

Grants and funding

This work was funded by the Ministry of Higher Education grant number 600-RMC/FRGS 5/3 (064/2021) and UiTM internal grant 600-RMC/SRC/5/3 (045/2020).

LinkOut - more resources